Prevalence of and risk factors for diabesity in urban Chennai



   Table of Contents   ORIGINAL ARTICLE Year : 2023  |  Volume : 14  |  Issue : 1  |  Page : 34-40

Prevalence of and risk factors for diabesity in urban Chennai

Aarthi Garudam Raveendiran1, Rajendra Pradeepa2, Venkatesan Ulagamathesan2, John Campbell Chambers3, Viswanathan Mohan4, Padma Venkatasubramanian5, Anjana Ranjit Mohan4
1 School of Public Health, SRM Institute of Science and Technology, Kattankulathur, India; Department of Research Operations, Madras Diabetes Research Foundation, Chennai, India
2 Department of Research Operations, Madras Diabetes Research Foundation, Chennai, India
3 School of Public Health, Imperial College London, London, UK
4 Department of Diabetology, Madras Diabetes Research Foundation and Dr.Mohan’s Diabetes Specialities Centre, Chennai, India
5 School of Public Health, SRM Institute of Science and Technology, Kattankulathur, India

Date of Submission17-Nov-2022Date of Decision08-Dec-2022Date of Acceptance14-Dec-2022Date of Web Publication18-Feb-2023

Correspondence Address:
Dr. Anjana Ranjit Mohan
Department of Diabetology, Dr.Mohans Diabetes Specialities centre, Madras Diabetes Research Foundation, 4, Conran Smith Road, Gopalapuram, Chennai- 600086, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jod.jod_121_22

Rights and Permissions

Background: A large number of epidemiologic studies across the world indicate a growing link between obesity and diabetes. The metropolitan city of Chennai in South India is experiencing an alarming increase in diabetes and obesity. Aim: The aim of this study was to determine the prevalence of and risk factors for diabetes and obesity together termed as “diabesity” among adults in urban Chennai. Materials and Methods: This was a community-based cross-sectional door-to-door study done as part of a large National Institute of Health and Care Research (NIHR)––a funded project aimed to understand patterns and determinants of health in South Asia. Of the 200 wards in Chennai, 34 wards were surveyed in the main project and two wards were selected randomly for this substudy. Five community enumeration blocks were selected using a systematic sampling technique. Participants aged ≥18 years were selected using a consecutive sampling method. Results: Of the 1138 participants studied, the prevalence of diabesity was found to be 34.3%(n = 390). Of the study participants, 74.8% had obesity (61.9%––generalized obesity; 68.5%––abdominal obesity) and 43.0% had diabetes. As age increased, the diabesity risk also increased gradually from 30 to 39 years (odds ratio [OR]: 3.6[95%, confidence interval [CI]: 1.4–8.9]) to 50–59 years (OR: 5.4[95%, CI: 2.2–13.2]), whereas there was a slight decrease in risk after 60 years (OR: 5.1[95%, CI: 2.1–12.3]). Females had nearly twice the risk of diabesity compared to men (OR: 1.8, P < 0.001), and physically inactive individuals had 1.7 times increased risk (P < 0.001). Conclusion: We report in this study that the prevalence of the dual metabolic defect (diabesity) is alarmingly high in urban Chennai. This study was an attempt to understand the epidemiology of diabesity.

Keywords: Diabesity, epidemiology, risk factors, urban


How to cite this article:
Raveendiran AG, Pradeepa R, Ulagamathesan V, Chambers JC, Mohan V, Venkatasubramanian P, Mohan AR. Prevalence of and risk factors for diabesity in urban Chennai. J Diabetol 2023;14:34-40
How to cite this URL:
Raveendiran AG, Pradeepa R, Ulagamathesan V, Chambers JC, Mohan V, Venkatasubramanian P, Mohan AR. Prevalence of and risk factors for diabesity in urban Chennai. J Diabetol [serial online] 2023 [cited 2023 Feb 19];14:34-40. Available from: https://www.journalofdiabetology.org/text.asp?2023/14/1/34/369991   Introduction Top

Obesity and diabetes are considered to be major public health issues globally.[1] Current available literature indicates a parallel increase in both obesity and diabetes.[1],[2],[3] Diabetes prevalence is increasing across the globe at a significant rate, according to the International Diabetes Federation (IDF), confirming diabetes as a major burden on individuals, families, and societies.[4] Type 2 diabetes mellitus (T2DM) accounts for 90% of all diabetes cases.[5] Globally, adults (20–79 years) with diabetes account for 537 million people and it is estimated to increase to 643 million by 2030 and 783 million by 2045.[4] Among the IDF regions, the South-East Asian region ranks second with 90 million people with diabetes, of which 82% (74 million) reside in India.[6] Similarly, the World Obesity Federation reports that in 2020, 764 million were living with obesity, a significant risk factor for T2DM, and predicts that by 2030 there will be one billion obese people worldwide, with the highest number of people living in developing countries like India.[7]

The term “diabesity,” which is defined as a coexistence of T2DM and obesity was first coined by Sims et al.[8] in 1973. Diabesity has substantial health consequences, including long-term diabetes complications, impairment in health-related functions, lowered quality of life, and reduced longevity.[3] A study conducted by Schnurr et al.[9] concluded that obesity raises the risk of developing T2DM 6-fold, regardless of genetic disposition. To curb this evolving epidemic of diabesity, screening, prevention, and early treatment are vital.[2] Several studies have emphasized the importance of reporting diabesity and recommended research in developing countries to understand the epidemiology of diabesity, its health burden, and its associated risk factors.[1],[2],[3],[10] Hence, this study aims to estimate the prevalence of “diabesity” and associated risk factors among the adult population in Chennai, south India.

  Materials and Methods Top

This is a community-based cross-sectional study which is part of a large health surveillance study to understand the patterns and determinants of health in South Asian people, carried out in four countries namely; India, Pakistan, Bangladesh, and Sri Lanka, funded by the National Institute for Health and Care Research. In India, there were two sites: Delhi and Chennai. In Delhi, the survey was conducted by Max Healthcare. In Chennai, the survey was conducted by the Madras Diabetes Research Foundation (MDRF). For this sub-study, the data from the Chennai site was used. The health surveillance study was carried out on a representative population of Chennai between May 2018 and September 2021. Chennai city has 15 zones and 200 wards, out of which 34 wards were systematically selected for the surveillance study, and two wards were randomly selected for this study. Five community enumeration blocks (CEBs) per ward were selected using simple random sampling techniques and were completely enumerated. Adults (men and women) aged ≥18 years living at their residence for more than 12 months were included in the study. Participants with severe mental or psychiatric illness, pregnant or breastfeeding, or other serious illness and subjects who do not give written consent were excluded from the study. Participants in the study were interviewed using structured and pretested health and lifestyle questionnaires that collected demographic, socioeconomic, medical, and family history of diabetes and heart disease, tobacco use, alcohol consumption, and fruit and vegetable consumption.

Physical activity was also captured using WHO STEP Global Physical activity questionnaire (GPAQ). To assess physical activity, metabolic equivalent (MET) scores were calculated separately for individual domains and subdomains, adopting existing guidelines. MET is the ratio of a person’s working metabolic rate to calorie expenditure. When calculating a person’s overall energy expenditure using GPAQ data, 4 METs were assigned to the time spent in moderate activities, and 8 METs to the time spent in vigorous activities.[11],[12]

Using standardized techniques, the following anthropometric measurements were collected from all participants: weight, height, and waist. Height was measured using (SECA Model 213, Hamburg, Deutschland) stadiometer. A bio-impedance machine, (Omron BF511, Omron Healthcare Group, Kyoto, Japan), was used to measure body mass index (BMI) and waist circumference was measured using a nonstretchable measuring tape.

Fasting venous blood samples were obtained the next day morning after participants observed a minimum of 8–10 h of fasting overnight. The venous blood samples were collected by trained technicians. Fasting plasma glucose (FPG) level was measured using AINA mini-Glucose meter (point-of-care device), Jana care, Inc., Boston, USA. HbA1c was measured using the Variant II Turbo machine, Bio-Rad Laboratories, Inc., USA.

This study was approved by the Institutional Ethics Committee of the MDRF, Chennai. Written informed consent was obtained from all subjects.

Definitions

Obesity

Generalized obesity (GO) was defined as BMI ≥25 kg/m2 for both sexes or abdominal obesity (AO), defined as waist circumference ≥90 cm for males and ≥80 cm for females.[13]

Diabetes

FPG ≥126 mg/dl[14] or HbA1c ≥6.5 or participants taking diabetes drugs.[15]

Diabesity

Individuals with both obesity and diabetes.

Physical activity

Individuals were classified based on MET-minutes into three groups as: inactive/low (<600 MET-minutes), active (600–1200 MET-minutes), and highly active (>1200 MET-minutes). In this study, the active and highly active groups were clubbed as an active group (≥600 MET-minutes).

Hypertension

Diagnosed in individuals who were on antihypertensive medications or had a systolic blood pressure (SBP) ≥140 mmHg and/or a diastolic blood pressure (DBP) ≥90 mmHg.[16]

Current smoking

Defined as self-reported smoking of tobacco products daily or on some days in the past 12 months.

Current alcohol use

Defined as self-reported use of alcohol daily or on some days in the past 12 months.

Statistical analysis

Statistical analysis was performed using SPSS statistical package version 24. Continuous variables were expressed as a mean and standard deviation whereas categorical variables were expressed as frequencies and percentages. Student’s t-test was used to compare means for continuous variables and the chi-square test was used for comparing proportions between two groups. Furthermore, univariate and multivariate logistic regression analyses were performed to examine the association using diabesity as a dependent variable while potential risk factors as independent variables. P value <0.05 was considered significant.

  Results Top

This study included 1138 individuals (male: n = 455 and females: n = 683) among whom, 26.3% had FPG levels ≥126 mg/dl, 25.6% had HbA1c ≥6.5%, 68.5% had abdominal obesity and 61.9% had generalized obesity. The prevalence of diabetes (FPG or HbA1c) and obesity (AO or GO) was 43, and 74.8%, respectively, and that of diabesity was 34.3% [Figure 1].

[Table 1] presents the demographic and biochemical characteristics of the study population. The mean age of the study population was 51 ± 13 years. Compared to men, women had significantly higher prevalence of diabesity (65.1%). In this study, overall, 59.3% of participants belonged to the middle-income group, who had a family income between 10,000 and 20,000 Indian Rupees, and 46.6% had a primary school education or less. Of the individuals with diabesity, 4.4% were smokers, 8.7% consumed alcohol, and 1.8% had five servings of fruits and vegetables per day. Physical inactivity was significantly higher among those with diabesity compared to those without (69 vs. 61.5%; P = 0.013).

Table 1: Demographic and biochemical characteristics of study population

Click here to view

[Figure 2] presents age-specific distributions of diabetes, obesity, and diabesity. The prevalence of obesity increased significantly from 53.4% in the age group 18–29 years to 80.6% in the 30–39 years age group and gradually reduced thereafter. A similar observation was seen with diabesity, which increased from 10.3% (18–29 years) to 29.4% (30–39 years). While, the prevalence of diabetes significantly increased from 24.1% in the age group, 18–29 years to 50.5% in the age group ≥ 60 years.

Figure 2: Age-wise distribution of obesity, diabetes, and diabesity. *P < 0.05 compared to 18–29 years; ** P for trend <0.05

Click here to view

[Figure 3] shows the distribution of diabetes, obesity, and diabesity by sex. The prevalence of obesity (82 vs. 64%, P < 0.001) and diabesity (37.2 vs. 29.9%, P < 0.01) was higher in females compared to males, respectively. There was no significant difference in the prevalence of diabetes among males (43.1%) and females (42.9%).

[Table 2] presents the univariate and multivariate logistic regression analysis with diabesity as the dependent variable, and variables associated with it in univariate analysis were used as the independent variables in the multivariate model. As age increased the diabesity risk also increased from 30 to 59 years (P < 0.05). However, there was a slight decrease in diabetes risk >60 years. Females had a higher risk of diabesity compared to men, the unadjusted odds for females was [odds ratio: 1.4 (95% confidence interval: 1.1–1.8)]. Considering the physically active group as a reference, the odds for developing diabesity was higher in individuals who were physically inactive. There was no significant association with fruit and vegetable intake, hypertension, and education levels. In the multivariate analysis, age, female gender, and physical inactivity were significantly associated with diabesity.

  Discussion Top

Diabesity, which refers to the coexistence of diabetes and obesity, is a major public health problem. To our knowledge, this is one of the few studies from India to assess the prevalence and risk factors of diabesity in a community-based study. The main findings of this study are as follows (i) the prevalence of diabesity was 34.3% among adults in urban Chennai; (ii) the prevalence of diabesity was significantly higher in females and with increasing age; and (iii) additionally physical inactivity was an independent predictor of diabesity.

Over the last few decades, both type 2 diabetes and obesity have increased rapidly worldwide, especially in developing countries like India, mainly due to growing urbanization and changes in human behavior, especially sedentary lifestyles (mechanical transportation, television watching, and lack of exercise, etc.,) and the influence of the western diet (increased availability of processed and fast food, consuming more “energy-dense, nutrient-poor” foods, etc.,).[17],[18],[19],[20] Asian Indians are more likely to develop AO and accumulate abdominal fat, which is referred to as the “Asian Indian phenotype”.[21],[22] As reported by the Indian Council of Medical Research (ICMR) - India Diabetes (INDIAB) study, in Tamil Nadu the prevalence rates for GO, AO, and combined obesity were 24.6%, 26.6%, and 19.3%, respectively.[23] Several studies have shown that women in India have a higher prevalence of obesity[23],[24] particularly in urban areas.[25] This could be attributed to the consumption of more saturated fats, have less physical activity, and dependency on mechanical transportation.[18] Menopause is considered to be one of the contributing factors to obesity among women.[26] The prevalence of AO [current study: 78% vs. National Family Health Survey 5 (NFHS-5): 59.5%] and GO (current study: 68.4% vs. NFHS-5: 41.9%) among females, were higher in the current study compared to that reported in the NFHS-5.[27] This might be due to the fact that NFHS-5 was conducted in the representative population of Chennai and this study was carried out in two selected wards.

As per the IDF, diabetes prevalence has increased in India over the past decade from 61.3 million in 2011[28] to 74.2 million in 2021.[4] According to the Global Burden of Disease Study, the number of people with diabetes increased from 26 million to 65 million between 1990 and 2016 in India, with the highest prevalence reported in Tamil Nadu.[29] The ICMR-INDIAB study conducted between 2008 and 2010 reported that the prevalence of diabetes in Tamil Nadu was 10.4%.[30] According to NFHS-5 conducted between 2019 and 2021, the prevalence of diabetes in Tamil Nadu was 20.7% in females and 22.1% in males, and the prevalence of obesity was reported to be 40.4% and 37.0% among females and males, respectively.[27]

The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) study conducted in Chennai in 2015 reported that the prevalence of diabetes was 22.8%.[31] The diabetes prevalence in Chennai was 27.2% for females and 22.1% for males, according to the NFHS-5.[27] In the current study, the diabetes prevalence was high (43%) compared to CARRS and NFHS-5. The NFHS-5 used random blood glucose values to identify diabetes, whereas the CARRS study used FPG or HbA1c or people taking diabetes medication, similar to this study.

A growing number of people have obesity or diabetes, leading to shorter life-span, reduced productivity, and significant economic losses.[30],[32],[33],[34] It is predicted that a 10% increase in overweight and obesity causes an increment of 4.7% in diabetes.[35] According to the Chennai Urban Rural Epidemiological Study (CURES), abdominal obesity contributes to diabetes incidence by 1.63 times.[36] The Global Burden of Disease Study reported that adults with a BMI ≥25 kg/m², increased from 9.0% to 20.4% between 1990 and 2016 and that in 2016, for every 100 adults with a BMI ≥25 kg/m² in India, there were 38 adults with diabetes, compared with the global average of 19 adults.[29] Very few studies have assessed the prevalence of diabesity. According to a study conducted in an urban Primary Health Center at Pondicherry, obesity prevalence in T2DM patients (diabesity) was reported to be 66.9%,[37] whereas another study conducted in Belagavi in Karnataka reported that the prevalence of obesity in T2DM patients was 53.4%.[38] Perhaps the higher prevalence of diabesity compared to the current study may be due to the studies being carried out in individuals with diabetes, rather than a general population.

Unhealthy diets, physical inactivity, and low income are considered the major risk factors for obesity.[23],[35] However, WHO and the IDF recommend that addressing obesity in the early stages can prevent future T2DM.[39] Therefore, obesity has been categorized as a major diabetes risk factor. Population growth, aging, urbanization, behavioral factors such as sedentary lifestyle and consuming calorie-rich diet, and environmental factors such as availability and accessibility of physical activity area and food outlet contribute to the increased prevalence of diabetes and obesity “diabesity”.[40],[41],[42]

In the past decade, several studies have reported physical inactivity to be common in developed and developing countries.[43],[44],[45],[46] Global trend in physical inactivity from 2001 to 2016, a pooled analysis from 358 population-based survey reported that the prevalence of insufficient physical activity over time increased from 31.6% in 2001 to 36.8% in the year 2016 in high-income countries whereas 16% in 2001 to 16.2% in the year 2016 in low-income countries.[47] The ICMR-INDIAB study conducted in four regions of India, including Tamil Nadu, assessed physical activity pattern using the GPAQ, reported that 54.4% of the population were inactive (urban 65% vs. rural 50%).[11] Our study findings show that 64% of the study population were physically inactive or follow a sedentary lifestyle, which is similar to the figures reported in the urban areas of India. According to the Global Burden of Disease Study (2016), among the risk factors contributing to diabetes, high BMI and low physical activity were associated with diabetes Daily Adjusted life years in India.[29]

This study has few limitations. In this study, causal inferences and generalizability of results are precluded due to its cross-sectional design. Another limitation is the relatively small sample drawn from a single city in India. Several studies have reported a significant relationship between diabetes, obesity, and diet, but this study did not thoroughly examine the dietary pattern in the study population. One of the strengths is that it is one of the few to examine diabesity prevalence in India and its associated risk factors from a community perspective. Diabesity studies so far have focused mostly on obesity prevalence in type 2 diabetes patients, mostly conducted in hospitals.

  Conclusion Top

In light of the rapid emergence of urban obesogenic environments across the country, diabetes prevention should be an urgent national priority. The current study found that the prevalence of dual metabolic defects (diabesity) to be alarmingly high in urban Chennai. This study made an effort to understand the epidemiology of diabesity which will help policymakers to design health programs to curb the rise of diabesity. More research studies are highly recommended in developing countries to identify the epidemiology of diabesity and its associated risk factors, for future prevention and intervention strategies.

Acknowledgments

The authors acknowledge the support of the National Institute for Health Research (NIHR) in carrying out this project.

Ethical clearance

This study was approved by Madras Diabetes Research Foundation Institutional Ethics Committee (Ref no: MDRF/NCT/06-01-2018).

Author disclosure statement

No competing financial interests exist.

Financial support and sponsorship

This research was supported by the National Institute for Health Research – Global Health Research Unit (NIHR-GHRU) (16/136/68) using UK aid from the UK Government to support global health research.

Conflicts of interest

There are no conflicts of interest.

 

  References Top
1.Colagiuri SD Therapeutic options. Diabetes Obes Metab 2010; 12:463-73.  Back to cited text no. 1
    2.Kalra S Diabesity. J Pak Med Assoc2013; 63:532-4.  Back to cited text no. 2
    3.Farag YMK, Gaballa MR Diabesity: An overview of a rising epidemic. Nephrol Dial Transplant 2011; 26:28-35.  Back to cited text no. 3
    4.IDF diabetes atlas. 10th ed. Brussels: International Diabetes Federation; 2021. (IDF Diabetes Atlas). Available from: http://www.ncbi.nlm.nih.gov/books/NBK581934/.  Back to cited text no. 4
    5.Goyal R, Jialal I Diabetes Mellitus Type 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Oct 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK513253/.  Back to cited text no. 5
    6.South-East Asia diabetes report 2000 — 2045[Internet]. [cited 2022 Oct 13]. Available from: https://diabetesatlas.org/data/. [Last accessed on 13 Oct 2022].  Back to cited text no. 6
    7.One billion people globally estimated to be living with obesity by 2030 [Internet]. World Obesity Federation. [cited 2022 Oct 13]. Available from: https://www.worldobesity.org/news/one-billion-people-globally-estimated-to-be-living-with-obesity-by-2030. [Last accessed on 13 Oct 2022].  Back to cited text no. 7
    8.Sims EAH, Danforth E, Horton ES, Bray GA, Glennon JA, Salans LB Endocrine and Metabolic Effects of Experimental Obesity in Man. In: Proceedings of the 1972 Laurentian Hormone Conference [Internet]. Elsevier; Amsterdam:Dutch Academic Publishing; 1973 [cited 2022 Oct 13]. p.457-96. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780125711296500166.  Back to cited text no. 8
    9.Schnurr TM, Jakupović H, Carrasquilla GD, Ängquist L, Grarup N, Sørensen TIA, et al. Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study. Diabetologia 2020; 63:1324-32.  Back to cited text no. 9
    10.Toplak H, Leitner DR, Harreiter J, Hoppichler F, Wascher TC, Schindler K, et al. [“Diabesity”-Obesity and type 2 diabetes (Update 2019)]. Wien Klin Wochenschr 2019; 131:71-6.  Back to cited text no. 10
    11.Anjana RM, Pradeepa R, Das AK, Deepa M, Bhansali A, Joshi SR, et al. Physical activity and inactivity patterns in India – results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]. Int J Behav Nutr Phys Act 2014; 11:26.  Back to cited text no. 11
    12.Physical activity[Internet]. [cited 2022 Oct 13]. Available from: https://www.who.int/news-room/fact-sheets/detail/physical-activity [Last accessed on 13 Oct 2022].  Back to cited text no. 12
    13.World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific perspective: Redefining obesity and its treatment [Internet]. Sydney: Health Communications Australia; 2000 [cited 2022 Oct 13]. p.55. Available from: https://apps.who.int/iris/handle/10665/206936. [Last accessed on 13 Oct 2022].  Back to cited text no. 13
    14.World Health Organization, Federation ID. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation [Internet]. World Health Organization; 2006 [cited 2022 Oct 13]. Available from: https://apps.who.int/iris/handle/10665/43588, [Last accessed on 13 Oct 2022].  Back to cited text no. 14
    15.World Health Organization. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: Abbreviated report of a WHO consultation. World Health Organization; 2011. Available from: https://apps.who.int/iris/handle/10665/70523. [Last accessed on 11 July 2022].  Back to cited text no. 15
    16.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206-52.  Back to cited text no. 16
    17.Zimmet P, Alberti KG, Shaw J Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-7.  Back to cited text no. 17
    18.Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser2003; 916:i-viii,1-149, backcover.  Back to cited text no. 18
    19.Misra A, Singhal N, Khurana L Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: Role of dietary fats and oils. J Am Coll Nutr 2010; 29(3 Suppl):289S-301S.  Back to cited text no. 19
    20.Malik VS, Willett WC, Hu FB Global obesity: Trends, risk factors and policy implications. Nat Rev Endocrinol 2013; 9:13-27.  Back to cited text no. 20
    21.Anjana RM, Baskar V, Nair ATN, Jebarani S, Siddiqui MK, Pradeepa R, et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: A data-driven cluster analysis: The INSPIRED study. BMJ Open Diabetes Res Care 2020; 8:e001506.  Back to cited text no. 21
    22.Mohan V, Rao GHR Type 2 diabetes in South Asians: Epidemiology, risk factors and prevention. Type 2 diabetes in South Asians: Epidemiology, risk factors and prevention [Internet]. 2007[cited 2022 Oct 13]; Available from: https://www.cabdirect.org/cabdirect/abstract/20093153897. [Last accessed on 3 Oct 2022].  Back to cited text no. 22
    23.Pradeepa R, Anjana RM, Joshi SR, Bhansali A, Deepa M, Joshi PP, et al. Prevalence of generalized & abdominal obesity in urban & rural India- the ICMR - INDIAB Study (Phase-I) [ICMR - INDIAB-3]. Indian J Med Res 2015; 142:139-50.  Back to cited text no. 23
[PUBMED]  [Full text]  24.Ahirwar R, Mondal PR Prevalence of obesity in India: A systematic review. Diabetes Metab Syndr 2019; 13:318-21.  Back to cited text no. 24
    25.Pandey RM, Gupta R, Misra A, Misra P, Singh V, Agrawal A, et al. Determinants of urban-rural differences in cardiovascular risk factors in middle-aged women in India: A cross-sectional study. Int J Cardiol 2013; 163:157-62.  Back to cited text no. 25
    26.Singhania K, Kalhan M, Choudhary P, Kumar T Association of menopausal symptoms with overweight and obesity among rural middle aged women in North India: A population based study. J Midlife Health 2020; 11:137-43.  Back to cited text no. 26
    27.National Family Health Survey (NFHS-5) [Internet]. [cited 2022 Oct 13]. Available from: http://rchiips.org/nfhs/districtfactsheet_NFHS-5.shtml. [Last accessed on 3 Oct 2022].  Back to cited text no. 27
    28.Whiting DR, Guariguata L, Weil C, Shaw J IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94:311-21.  Back to cited text no. 28
    29.Tandon N, Anjana RM, Mohan V, Kaur T, Afshin A, Ong K, et al. The increasing burden of diabetes and variations among the states of India: The global burden of disease study 1990-2016. The Lancet Global Health 2018; 6:e1352-62.  Back to cited text no. 29
    30.Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017; 5:585-96.  Back to cited text no. 30
    31.Deepa M, Grace M, Binukumar B, Pradeepa R, Roopa S, Khan HM, et al. High burden of prediabetes and diabetes in three large cities in South Asia: The center for cArdio-metabolic risk reduction in South Asia (CARRS) study. Diabetes Res Clin Pract 2015; 110:172-82.  Back to cited text no. 31
    32.Goettler A, Grosse A, Sonntag D Productivity loss due to overweight and obesity: A systematic review of indirect costs. BMJ Open 2017; 7:e014632.  Back to cited text no. 32
    33.Oberoi S, Kansra P Economic menace of diabetes in India: A systematic review. Int J Diabetes Dev Ctries 2020; 40:464-75.  Back to cited text no. 33
    34.Pradeepa R, Mohan V Epidemiology of type 2 diabetes in India. Indian J Ophthalmol 2021; 69:2932-8.  Back to cited text no. 34
    35.Marbaniang SP, Lhungdim H, Yadav B, Yajurvedi VK Overweight/obesity risks and prevalence of diabetes and hypertension in North Eastern India: An analysis using seemingly unrelated probit model. Clinical Epidemiology and Global Health 2021; 11: 100764.  Back to cited text no. 35
    36.Anjana RM, Sudha V, Nair DH, Lakshmipriya N, Deepa M, Pradeepa R, et al. Diabetes in Asian Indians-how much is preventable? Ten-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES-142). Diabetes Res Clin Pract 2015; 109:253-61.  Back to cited text no. 36
    37.Rehman T, Rajaa S, Kumar G, Jayalakshmy R Prevalence and factors influencing diabesity among persons with type 2 diabetes mellitus in urban Puducherry: A cross-sectional analytical study. Indian J Community Med 2020; 45:315-9.  Back to cited text no. 37
    38.Vasanthakumar J, Kambar S Prevalence of obesity among type 2 diabetes mellitus patients in urban areas of Belagavi. Indian J Health Sci Biomed Res (KLEU). 2020; 13:21.  Back to cited text no. 38
    39.IDF and WOF release new policy brief to address obesity and type 2 diabetes. Diabetes Research and Clinical Practice [Internet]. 2022 Apr 1 [cited 2022 Oct 13]; 186. Available from: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(22)00677-5/fulltext. [Last accessed on 5 Oct 2022].  Back to cited text no. 39
    40.Ershow AG Environmental influences on development of type 2 diabetes and obesity: Challenges in personalizing prevention and management. J Diabetes Sci Technol 2009; 3:727-34.  Back to cited text no. 40
    41.Wild S, Roglic G, Green A, Sicree R, King H Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-53.  Back to cited text no. 41
    42.Al-Goblan AS, Al-Alfi MA, Khan MZ Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 2014; 7:587-91.  Back to cited text no. 42
    43.Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U, et al. Global physical activity levels: Surveillance progress, pitfalls, and prospects. Lancet 2012; 380:247-57.  Back to cited text no. 43
    44.Larouche R Physical inactivity in developing countries. CMAJ 2014; 186:1092.  Back to cited text no. 44
    45.Muthuri SK, Wachira LJM, Leblanc AG, Francis CE, Sampson M, Onywera VO, et al. Temporal trends and correlates of physical activity, sedentary behaviour, and physical fitness among school-aged children in sub-Saharan Africa: A systematic review. Int J Environ Res Public Health 2014; 11:3327-59.  Back to cited text no. 45
    46.Dumith SC, Hallal PC, Reis RS, Kohl HW Worldwide prevalence of physical inactivity and its association with human development index in 76 countries. Prev Med 2011; 53:24-8.  Back to cited text no. 46
    47.Guthold R, Stevens GA, Riley LM, Bull FC Worldwide trends in insufficient physical activity from 2001 to 2016: A pooled analysis of 358 population-based surveys with 1·9 million participants. The Lancet Global Health 2018; 6:e1077-86.  Back to cited text no. 47
    
  [Figure 1], [Figure 2], [Figure 3]
 
 
  [Table 1], [Table 2]
  Top  

留言 (0)

沒有登入
gif